{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:04:12Z","timestamp":1762459452537,"version":"3.37.3"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,12,19]],"date-time":"2016-12-19T00:00:00Z","timestamp":1482105600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s00404-016-4265-9","type":"journal-article","created":{"date-parts":[[2016,12,19]],"date-time":"2016-12-19T06:47:27Z","timestamp":1482130047000},"page":"681-687","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The impact of ultra-radical surgery in the management of patients with stage IIIC and IV epithelial ovarian, fallopian tube, and peritoneal cancer"],"prefix":"10.1007","volume":"295","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6669-571X","authenticated-orcid":false,"given":"Hilary L.","family":"Turnbull","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Akrivos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Wemyss-Holden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Balachandra","family":"Maiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy J.","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaquin J.","family":"Nieto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Burbos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,12,19]]},"reference":[{"key":"4265_CR1","unstructured":"Ovarian cancer incidence statistics (2016) Cancer research UK. Accessed 15 Jun 2016"},{"issue":"Suppl 1","key":"4265_CR2","doi-asserted-by":"publisher","first-page":"S161","DOI":"10.1016\/S0020-7292(06)60033-7","volume":"95","author":"AP Heintz","year":"2006","unstructured":"Heintz AP, Odicino F, Maisonneuve P, Quinn MA, Benedet JL, Creasman WT, Ngan HY, Pecorelli S, Beller U (2006) Carcinoma of the ovary. FIGO 26th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet 95(Suppl 1):S161\u2013S192. doi: 10.1016\/S0020-7292(06)60033-7","journal-title":"Int J Gynaecol Obstet"},{"issue":"6","key":"4265_CR3","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/cncr.24149","volume":"115","author":"A Bois du","year":"2009","unstructured":"du Bois A, Reuss A, Pujade-Lauraine E, Harter P, Ray-Coquard I, Pfisterer J (2009) Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d\u2019Investigateurs Nationaux Pour les Etudes des Cancers de l\u2019Ovaire (GINECO). Cancer 115(6):1234\u20131244. doi: 10.1002\/cncr.24149","journal-title":"Cancer"},{"issue":"9","key":"4265_CR4","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1200\/JCO.2008.19.1684","volume":"27","author":"MA Bookman","year":"2009","unstructured":"Bookman MA, Brady MF, McGuire WP, Harper PG, Alberts DS, Friedlander M, Colombo N, Fowler JM, Argenta PA, De Geest K, Mutch DG, Burger RA, Swart AM, Trimble EL, Accario-Winslow C, Roth LM (2009) Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a phase III trial of the Gynecologic Cancer Intergroup. J Clin Oncol 27(9):1419\u20131425. doi: 10.1200\/JCO.2008.19.1684","journal-title":"J Clin Oncol"},{"issue":"6","key":"4265_CR5","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1245\/s10434-010-0964-9","volume":"17","author":"P Wimberger","year":"2010","unstructured":"Wimberger P, Wehling M, Lehmann N, Kimmig R, Schmalfeldt B, Burges A, Harter P, Pfisterer J, du Bois A (2010) Influence of residual tumor on outcome in ovarian cancer patients with FIGO stage IV disease: an exploratory analysis of the AGO-OVAR (Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group). Ann Surg Oncol 17(6):1642\u20131648. doi: 10.1245\/s10434-010-0964-9","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"4265_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ygyno.2009.03.018","volume":"114","author":"DS Chi","year":"2009","unstructured":"Chi DS, Eisenhauer EL, Zivanovic O, Sonoda Y, Abu-Rustum NR, Levine DA, Guile MW, Bristow RE, Aghajanian C, Barakat RR (2009) Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm. Gynecol Oncol 114(1):26\u201331. doi: 10.1016\/j.ygyno.2009.03.018","journal-title":"Gynecol Oncol"},{"issue":"3","key":"4265_CR7","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.ygyno.2013.05.040","volume":"130","author":"SJ Chang","year":"2013","unstructured":"Chang SJ, Hodeib M, Chang J, Bristow RE (2013) Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: a meta-analysis. Gynecol Oncol 130(3):493\u2013498. doi: 10.1016\/j.ygyno.2013.05.040","journal-title":"Gynecol Oncol"},{"key":"4265_CR8","unstructured":"Ovarian Cancer (2011) National Institute for Health and Clinical Excellence UK NICE Clinical Guideline 122"},{"key":"4265_CR9","unstructured":"Ultra-radical (extensive) surgery for advanced ovarian cancer (2013) National Institute for Health and Clinical Excellence UK NICE interventional procedure guidance (IPG470). https:\/\/www.nice.org.uk\/guidance\/ipg470. Accessed 11 Dec 2016"},{"issue":"3","key":"4265_CR10","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ygyno.2009.11.022","volume":"116","author":"O Zivanovic","year":"2010","unstructured":"Zivanovic O, Sima CS, Iasonos A, Hoskins WJ, Pingle PR, Leitao MM Jr, Sonoda Y, Abu-Rustum NR, Barakat RR, Chi DS (2010) The effect of primary cytoreduction on outcomes of patients with FIGO stage IIIC ovarian cancer stratified by the initial tumor burden in the upper abdomen cephalad to the greater omentum. Gynecol Oncol 116(3):351\u2013357. doi: 10.1016\/j.ygyno.2009.11.022","journal-title":"Gynecol Oncol"},{"issue":"3","key":"4265_CR11","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s00404-016-4080-3","volume":"294","author":"C Fotopoulou","year":"2016","unstructured":"Fotopoulou C, Jones BP, Savvatis K, Campbell J, Kyrgiou M, Farthing A, Brett S, Roux R, Hall M, Rustin G, Gabra H, Jiao L, Stumpfle R (2016) Maximal effort cytoreductive surgery for disseminated ovarian cancer in a UK setting: challenges and possibilities. Arch Gynecol Obstet 294(3):607\u2013614. doi: 10.1007\/s00404-016-4080-3","journal-title":"Arch Gynecol Obstet"},{"issue":"8","key":"4265_CR12","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/jnci\/dji102","volume":"97","author":"PB Panici","year":"2005","unstructured":"Panici PB, Maggioni A, Hacker N, Landoni F, Ackermann S, Campagnutta E, Tamussino K, Winter R, Pellegrino A, Greggi S, Angioli R, Manci N, Scambia G, Dell\u2019Anna T, Fossati R, Floriani I, Rossi RS, Grassi R, Favalli G, Raspagliesi F, Giannarelli D, Martella L, Mangioni C (2005) Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial. J Natl Cancer Inst 97(8):560\u2013566. doi: 10.1093\/jnci\/dji102","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"4265_CR13","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S1072-7515(03)00478-2","volume":"197","author":"RE Bristow","year":"2003","unstructured":"Bristow RE, del Carmen MG, Kaufman HS, Montz FJ (2003) Radical oophorectomy with primary stapled colorectal anastomosis for resection of locally advanced epithelial ovarian cancer. J Am Coll Surg 197(4):565\u2013574. doi: 10.1016\/S1072-7515(03)00478-2","journal-title":"J Am Coll Surg"},{"issue":"2","key":"4265_CR14","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.ygyno.2007.10.022","volume":"108","author":"EL Eisenhauer","year":"2008","unstructured":"Eisenhauer EL, Abu-Rustum NR, Sonoda Y, Aghajanian C, Barakat RR, Chi DS (2008) The effect of maximal surgical cytoreduction on sensitivity to platinum-taxane chemotherapy and subsequent survival in patients with advanced ovarian cancer. Gynecol Oncol 108(2):276\u2013281. doi: 10.1016\/j.ygyno.2007.10.022 (S0090-8258(07)00862-1 [pii])","journal-title":"Gynecol Oncol"},{"issue":"2","key":"4265_CR15","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.ygyno.2006.03.051","volume":"103","author":"DS Chi","year":"2006","unstructured":"Chi DS, Eisenhauer EL, Lang J, Huh J, Haddad L, Abu-Rustum NR, Sonoda Y, Levine DA, Hensley M, Barakat RR (2006) What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? Gynecol Oncol 103(2):559\u2013564. doi: 10.1016\/j.ygyno.2006.03.051","journal-title":"Gynecol Oncol"},{"issue":"2","key":"4265_CR16","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0090-8258(03)00278-6","volume":"90","author":"SM Eisenkop","year":"2003","unstructured":"Eisenkop SM, Spirtos NM, Friedman RL, Lin WC, Pisani AL, Perticucci S (2003) Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study. Gynecol Oncol 90(2):390\u2013396","journal-title":"Gynecol Oncol"},{"issue":"1","key":"4265_CR17","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s00404-015-3813-z","volume":"293","author":"C Bian","year":"2016","unstructured":"Bian C, Yao K, Li L, Yi T, Zhao X (2016) Primary debulking surgery vs. neoadjuvant chemotherapy followed by interval debulking surgery for patients with advanced ovarian cancer. Arch Gynecol Obstet 293(1):163\u2013168. doi: 10.1007\/s00404-015-3813-z","journal-title":"Arch Gynecol Obstet"},{"issue":"10","key":"4265_CR18","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1056\/NEJMoa0908806","volume":"363","author":"I Vergote","year":"2010","unstructured":"Vergote I, Trope CG, Amant F, Kristensen GB, Ehlen T, Johnson N, Verheijen RH, van der Burg ME, Lacave AJ, Panici PB, Kenter GG, Casado A, Mendiola C, Coens C, Verleye L, Stuart GC, Pecorelli S, Reed NS, European Organization for R, Treatment of Cancer-Gynaecological Cancer G, Group NCT (2010) Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N Engl J Med 363(10):943\u2013953. doi: 10.1056\/NEJMoa0908806","journal-title":"N Engl J Med"},{"issue":"9990","key":"4265_CR19","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0140-6736(14)62223-6","volume":"386","author":"S Kehoe","year":"2015","unstructured":"Kehoe S, Hook J, Nankivell M, Jayson GC, Kitchener H, Lopes T, Luesley D, Perren T, Bannoo S, Mascarenhas M, Dobbs S, Essapen S, Twigg J, Herod J, McCluggage G, Parmar M, Swart AM (2015) Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial. Lancet 386(9990):249\u2013257. doi: 10.1016\/S0140-6736(14)62223-6","journal-title":"Lancet"},{"issue":"2","key":"4265_CR20","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ygyno.2013.08.007","volume":"131","author":"DP Barton","year":"2013","unstructured":"Barton DP, Adib T, Butler J (2013) Surgical practice of UK gynaecological oncologists in the treatment of primary advanced epithelial ovarian cancer (PAEOC): a questionnaire survey. Gynecol Oncol 131(2):347\u2013351. doi: 10.1016\/j.ygyno.2013.08.007","journal-title":"Gynecol Oncol"},{"issue":"3","key":"4265_CR21","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/bjc.2014.630","volume":"112","author":"R Iyer","year":"2015","unstructured":"Iyer R, Gentry-Maharaj A, Nordin A, Burnell M, Liston R, Manchanda R, Das N, Desai R, Gornall R, Beardmore-Gray A, Nevin J, Hillaby K, Leeson S, Linder A, Lopes A, Meechan D, Mould T, Varkey S, Olaitan A, Rufford B, Ryan A, Shanbhag S, Thackeray A, Wood N, Reynolds K, Menon U (2015) Predictors of complications in gynaecological oncological surgery: a prospective multicentre study (UKGOSOC-UK gynaecological oncology surgical outcomes and complications). Br J Cancer 112(3):475\u2013484. doi: 10.1038\/bjc.2014.630","journal-title":"Br J Cancer"},{"issue":"1","key":"4265_CR22","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/01.AOG.0000192407.04428.bb","volume":"107","author":"GD Aletti","year":"2006","unstructured":"Aletti GD, Dowdy SC, Gostout BS, Jones MB, Stanhope CR, Wilson TO, Podratz KC, Cliby WA (2006) Aggressive surgical effort and improved survival in advanced-stage ovarian cancer. Obstet Gynecol 107(1):77\u201385. doi: 10.1097\/01.AOG.0000192407.04428.bb","journal-title":"Obstet Gynecol"},{"issue":"31","key":"4265_CR23","doi-asserted-by":"publisher","first-page":"4946","DOI":"10.1200\/JCO.2007.12.2317","volume":"25","author":"DS Chi","year":"2007","unstructured":"Chi DS, Ramirez PT, Teitcher JB, Mironov S, Sarasohn DM, Iyer RB, Eisenhauer EL, Abu-Rustum NR, Sonoda Y, Levine DA, Brown CL, Aghajanian C, Gershenson DM, Hoskins WJ, Hricak H, Barakat RR (2007) Prospective study of the correlation between postoperative computed tomography scan and primary surgeon assessment in patients with advanced ovarian, tubal, and peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residual disease 1\u00a0cm or less. J Clin Oncol 25(31):4946\u20134951. doi: 10.1200\/JCO.2007.12.2317","journal-title":"J Clin Oncol"},{"issue":"1","key":"4265_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ygyno.2016.05.022","volume":"143","author":"AA Wright","year":"2016","unstructured":"Wright AA, Bohlke K, Armstrong DK, Bookman MA, Cliby WA, Coleman RL, Dizon DS, Kash JJ, Meyer LA, Moore KN, Olawaiye AB, Oldham J, Salani R, Sparacio D, Tew WP, Vergote I, Edelson MI (2016) Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline. Gynecol Oncol 143(1):3\u201315. doi: 10.1016\/j.ygyno.2016.05.022","journal-title":"Gynecol Oncol"},{"issue":"3","key":"4265_CR25","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1097\/AOG.0b013e31822a6d56","volume":"118","author":"MM Thrall","year":"2011","unstructured":"Thrall MM, Goff BA, Symons RG, Flum DR, Gray HJ (2011) Thirty-day mortality after primary cytoreductive surgery for advanced ovarian cancer in the elderly. Obstet Gynecol 118(3):537\u2013547. doi: 10.1097\/AOG.0b013e31822a6d56","journal-title":"Obstet Gynecol"},{"issue":"9972","key":"4265_CR26","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/S0140-6736(14)62038-9","volume":"385","author":"C Allemani","year":"2015","unstructured":"Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, Bannon F, Ahn JV, Johnson CJ, Bonaventure A, Marcos-Gragera R, Stiller C, Azevedo e Silva G, Chen WQ, Ogunbiyi OJ, Rachet B, Soeberg MJ, You H, Matsuda T, Bielska-Lasota M, Storm H, Tucker TC, Coleman MP (2015) Global surveillance of cancer survival 1995\u20132009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet 385(9972):977\u20131010. doi: 10.1016\/S0140-6736(14)62038-9","journal-title":"Lancet"},{"key":"4265_CR27","unstructured":"du Bois A, Harter P (2010) Understanding and optimizing the potential role of surgical debulking in advanced epithelial ovarian cancer. Am Soc Clin Oncol Ed Book e13\u2013e17"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-016-4265-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-016-4265-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-016-4265-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T02:14:18Z","timestamp":1498356858000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-016-4265-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,19]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["4265"],"URL":"https:\/\/doi.org\/10.1007\/s00404-016-4265-9","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"type":"print","value":"0932-0067"},{"type":"electronic","value":"1432-0711"}],"subject":[],"published":{"date-parts":[[2016,12,19]]}}}